
The growth of vertebrate animals from neonatal to adult size depends upon the proper functioning of the hypothalamic/pituitary/end organ system known as the growth hormone axis. In Laron-type dwarves, in whom growth hormone (GH) insensitivity results from the absence of GHR signalling, increased growth velocity can be stimulated with the injection of insulin-like growth factor-I, although hypoglycaemia is a common side effect. The complexity of the hypothalamic/pituitary growth axis can be further appreciated by consideration of the variety of growth dynamics among species. At one extreme are animals such as rats and pigs, which continue somatic growth indefinitely into adulthood. In addition, an ever increasing number of animal model systems, both naturally occurring and transgenic, have facilitated the in vivo study of animal growth. The most severe form of growth deficiency, called isolated GH deficiency, type IA, is caused by mutation or deletion of GH-N.
The major hormonal regulators of glucose homeostasis are glucagon and insulin. Defects in the mechanism controlling glucose homeostasis are relatively common in humans, the most widespread of these being diabetes. The endocrine pancreas is made up of four major cell types and the regulated secretion of peptide hormones from these cells provides the main mechanism by which the body achieves glucose homeostasis. The effects of insulin on glucose homeostasis are largely mediated through a reduction in hepatic glucose output with simultaneous stimulation of glucose uptake into muscle and adipose tissue. The importance of hepatic glycogenolysis and glucose-6-phosphatase in regulating whole body glucose homeostasis is illustrated by the pathophysiology of type-1 glycogen storage disease. The close links between obesity and insulin resistance suggest that events occurring in adipose tissue may influence whole body glucose homeostasis. The insulin receptor has a crucial role in glucose homeostasis and decreasing levels of insulin receptor function are inversely related to the degree of insulin resistance.
The discovery of parathyroid hormone-related protein (PTHrP) resulted from investigations of the mechanisms by which certain cancers cause hypercalcaemia without necessarily metastasizing to bone. PTHrP and IL-1 can synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Elevated PTHrP levels have also been found in a proportion of patients with haematological malignancies and hypercalcaemia. The marked species conservation of the PTHrP sequence over these 111 amino acids indicates that important functions are likely to reside in this region. The existence of multiple PTHrP mRNA species as shown by Northern blot analysis and the demonstration of 5' and 3' divergent cDNA clones indicated that PTHrP transcripts may be alternatively spliced or that the transcripts result from a multigene family. The properties outlined suggest that PTHrP should be considered as a cytokine and support the proposal that PTHrP is a member of the early response gene family.
The biosynthesis of steroid hormones is the result of sequential hydroxylation and isomerization reactions which convert cholesterol to the physiologically active mineralocorticoids, glucocorticoids, androgens and oestrogens. The major sites of steroidogenesis are the ovaries, testes, adrenal glands and placenta although other organs such as the brain, liver and adipose tissue can play a significant role. A number of factors determine whether a steroid molecule will remain on the single active site of CYP17 and undergo cleavage of the 17,20 bond to produce androgens. Cholesterol can be synthesized from acetate in all steroidogenic tissues but the favoured route is to obtain the steroid from dietary sources via low density lipoprotein. The mechanism by which steroidogenesis is limited to a small number of tissues is not understood. The first line of tissue specificity must be the presence or absence of receptors for the various trophic hormones.